DCP
IDXX icon

DSM Capital Partners’s Idexx Laboratories IDXX Stock Holding History

DSM Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-68
Closed -$34.4K – 69
2024
Q3 		$34.4K Hold
68
– – ﹤0.01% 77
2024
Q2 		$33.1K Hold
68
– – ﹤0.01% 82
2024
Q1 		$36.7K Buy
68
+8
+13% +$4.37K ﹤0.01% 84
2023
Q4 		$33.3K Buy
+60
New +$28.2K ﹤0.01% 84

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DSM Capital Partners's IDXX Position: Q4 2024 in Review

DSM Capital Partners sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 68 shares — an estimated $34.4K sold.

DSM Capital Partners first reported a position in IDXX in Q4 2023 and held it in 4 quarters. The position peaked at $36.7K in Q1 2024. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • DSM Capital Partners reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • DSM Capital Partners sold 68 Idexx Laboratories shares in Q4 2024, an estimated $34.4K.
  • DSM Capital Partners first reported a position in Idexx Laboratories in Q4 2023 and held it in 4 quarters.
  • DSM Capital Partners's Idexx Laboratories position peaked at $36.7K in Q1 2024.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on DSM Capital Partners's 13F filing for Q4 2024, filed 31 Jan 2025.